Stock GENOVIS AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Genovis AB Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm
Other stock markets
- SEK - Intraday chart for Genovis AB
15/05 Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/03 Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement CI

Chart calendar Genovis AB

6f698728707d77df8375d595fe48166.nitd8v61eU_mlq1wQHw5pa10HM02yLXMj2y_nK-d8J4.6Rk0vsb4FziVoucnM05gx4BCe6VcuMKT6ADy_5nLos-qbgWXydQrH9Sg5A~d4e3931d5657ab5c25f6ee5aa37cc357

Upcoming events on Genovis AB

20/08/2024 11:30 am Q2 2024 Earnings Release
08/11/2024 12:30 pm Q3 2024 Earnings Release
05/02/2025 Q4 2024 Earnings Release (Projected)
24/04/2025 Q1 2025 Earnings Release (Projected)
08/08/2025 Q2 2025 Earnings Release (Projected)
07/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Genovis AB

15/05/2024 Q1 2024 Earnings Release
15/02/2024 Q4 2023 Earnings Release
15/11/2023 Q3 2023 Earnings Release
24/08/2023 Q2 2023 Earnings Release
16/05/2023 Q1 2023 Earnings Release
15/02/2023 FY 2022 Earnings Release
15/11/2022 Q3 2022 Earnings Release
12/08/2022 11:30 am Interim 2022 Earnings Release
12/05/2022 Annual General Meeting
27/04/2022 11:30 am Q1 2022 Earnings Release
08/02/2022 FY 2021 Earnings Release
12/11/2021 04:30 pm Q3 2021 Earnings Release
12/08/2021 Interim 2021 Earnings Release
29/04/2021 Q1 2021 Earnings Release
11/02/2021 FY 2020 Earnings Release
05/11/2020 Q3 2020 Earnings Release
13/08/2020 Interim 2020 Earnings Release
05/05/2020 06:30 pm Annual General Meeting
29/04/2020 11:30 am Q1 2020 Earnings Release
05/02/2020 FY 2019 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK		Released
Forecast
Spread 		60,5
62,0
-2.34%		61,0
58,7
3.97%		93,0
74,7
24.52%		102
106
-3.41%		158
193
-17.97%
137

EBITDA
Million SEK		Released
Forecast
Spread 		13,6
16,0
-15.23%		8,57
6,40
33.95%		30,3
48,1
-36.98%		23,9
29,6
-19.09%		63,9
103
-38.04%
51,2

EBIT
Million SEK		Released
Forecast
Spread 		10,1
12,0
-16.12%		3,14
1,00
214%		24,5
42,3
-41.98%		17,3
22,8
-24.22%		55,8
93,3
-40.16%
39,3

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		9,67
11,0
-12.12%		2,15
0,20
974.5%		24,6
42,4
-41.97%		8,00
22,8
-64.93%		54,9
84,5
-35.09%
39,3

Net income
Million SEK		Released
Forecast
Spread 		9,55
11,0
-13.17%		6,45
0,20
3123%		24,8
42,2
-41.29%		11,2
26,5
-57.78%		61,5
87,1
-29.39%
31,2

EPS
SEK		Released
Forecast
Spread 		0,15
0,20
-25%		0,10
0,00
- 		0,41
0,65
-36.92%		0,19
0,43
-55.6%		0,94
1,34
-29.68%
0,48

Announcement Date05/02/2011/02/2108/02/2215/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million SEK		Released
Forecast
Spread 		32,6
0,00
- 		21,1
23,8
-11.19%		23,0
25,6
-10.24%		25,7
28,3
-9.04%		71,3
71,6
-0.45%		29,5
44,4
-33.64%		30,2
30,5
-0.87%		27,3
32,6
-16.24%		40,1
36,5
9.9%
31,3


32,7


33,0

EBITDA
Million SEK		Released
Forecast
Spread 		11,7
0,00
- 		2,11
5,00
-57.82%		7,00
5,55
26.07%		3,09
6,85
-54.96%		45,1
38,8
16.21%		7,69
19,9
-61.27%		8,19
5,75
42.49%		3,62
7,10
-49.08%		18,6
14,2
30.76%
10,3


12,3


20,9

EBIT
Million SEK		Released
Forecast
Spread 		10,1
0,00
- 		0,22
3,25
-93.2%		4,99
4,05
23.28%		1,96
5,35
-63.42%		43,4
37,8
14.81%		5,98
18,4
-67.41%		5,66
4,23
33.75%		0,76
4,50
-83.11%		15,8
11,6
36.1%
7,86


9,25


17,8

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread


0,21
7,50
-97.19%		5,01
4,05
23.65%		-7,27
5,80
-225.41%		43,7
37,5
16.63%		6,62
5,50
20.31%		4,27
5,60
-23.77%		0,23
3,60
-93.72%		16,0
13,1
21.87%








Net income
Million SEK		Released
Forecast
Spread 		12,3
0,00
- 		0,67
2,10
-68%		5,71
2,90
96.83%		-7,51
5,80
-229.45%		43,6
37,5
16.17%		15,2
5,30
187.15%		3,14
4,70
-33.23%		-0,42
4,05
-110.42%		12,7
8,80
44.8%
6,29


6,78


3,75

EPS
SEK		Released
Forecast
Spread


0,01
-0,01
200%		0,09
0,00
- 		-0,11
0,09
-222.22%		0,67
0,60
11.67%		0,23
0,08
187.5%		0,05
0,10
-50%		-0,01
0,32
-103.17%		0,19
0,14
40.74%
1,13


1,28


-0,11

Announcement Date27/04/2212/08/2215/11/2215/02/2316/05/2324/08/2315/11/2315/02/2415/05/24---

Upcoming sector events for Genovis AB

17/07/2024 11:30 am VITROLIFE AB: Q2 2024 Earnings Release
30/07/2024 AMOY DIAGNOSTICS CO., LTD.: Q2 2024 Earnings Release (Projected)
01/08/2024 MYRIAD GENETICS, INC.: Q2 2024 Earnings Release (Projected)
01/08/2024 LANTHEUS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
01/08/2024 10X GENOMICS, INC.: Q2 2024 Earnings Release (Projected)
01/08/2024 MACCURA BIOTECHNOLOGY CO.LTD: Q2 2024 Earnings Release (Projected)
01/08/2024 SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.: Q2 2024 Earnings Release (Projected)
01/08/2024 DIASORIN S.P.A.: Q2 2024 Earnings Release
05/08/2024 CASTLE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
09/08/2024 SD BIOSENSOR, INC: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Genovis AB

16/05/2024 SD BIOSENSOR, INC: Q1 2024 Earnings Release
10/05/2024 06:51 pm DIASORIN S.P.A.: Q1 2024 Earnings Release
08/05/2024 01:35 am MYRIAD GENETICS, INC.: Q1 2024 Earnings Release
03/05/2024 01:35 am CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release
02/05/2024 04:30 pm LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release
01/05/2024 01:35 am 10X GENOMICS, INC.: Q1 2024 Earnings Release
30/04/2024 ASSURE TECH (HANGZHOU) CO., LTD.: Q1 2024 Earnings Release
30/04/2024 SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q1 2024 Earnings Release
30/04/2024 SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q4 2023 Earnings Release
30/04/2024 ZHEJIANG ORIENT GENE BIOTECH CO.,LTD: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. GENO Stock
  4. Stock
  5. Calendar Genovis AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW